GSK vs GILD

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jul 06, 2026

GSK

66.5
AI Score
VS
GILD Wins

GILD

66.8
AI Score

Investment Advisor Scores

GSK

67score
Recommendation
BUY

GILD

67score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric GSK GILD Winner
Forward P/E 22.4719 15.2207 GILD
PEG Ratio 20.2545 2.1441 GILD
Revenue Growth 1.5% 4.4% GILD
Earnings Growth 8.4% 54.8% GILD
Tradestie Score 66.5/100 66.8/100 GILD
Profit Margin 17.8% 31.0% GILD
Beta 1.00 1.00 Tie
AI Recommendation BUY BUY Tie

Frequently Asked Questions

Based on our detailed analysis, GILD is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.